Feed/Companies/Expedition Therapeutics -

Expedition Therapeutics -

As of 14 Oct 2026, Expedition Therapeutics - has raised $165M across 1 verified round on record; latest: $165 million Series A led by Novo Holdings and Sofinnova Partners, announced 9 Oct 2025.

BUILT ON

Visit site

Expedition Therapeutics develops novel treatments for inflammatory and respiratory diseases, specifically targeting chronic obstructive pulmonary disease (COPD).

expeditiontx.comBiotech

LATEST ROUND

Series A

$165M · 2025-10-09

RAISED ON RECORD · USD

$165M

across 1 verified round

INVESTORS

2 leads

SOURCES

from 1 publisher

Rounds

[ 1 ]

Feed/Companies

Company

Every round on record, with the sources behind each and the investors on them.

BUILT ON

Round	Amount	Announced	Lead	Buzz
Series A [ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it.	$165M	2025-10-09	Novo Holdings, Sofinnova Partners	No recent discussion
1 source [ VERIFIED ] read against 1 source No valuation, financing total, or headquarters is stated; San Francisco is a dateline, not evidence of headquarters. [ BUILT WITH ]·[ SEARCH ]found by Firecrawl search·[ SCRAPE ]1 page read: businesswire.com·[ JSON ]round read into a schema, with the sentence that states it·[ VERIFY ]confirmedchecked against 1 source·[ BRANDING ]logo and colour from the homepage

Expedition Therapeutics -

Rounds

Company

Rounds

Sources

Profile

Investors

Expedition Therapeutics -

Rounds

Profile

Sources

Series A$165M2025-10-091 source

Investors

Series A$165M2025-10-0910 investors